July 15, 2021

Medical Monitor’s Conundrum: Making Sense of Site/ Central Discordance in Radiology Assessment

This article provides an overview and guidance on managing the disagreements that occur between the interpretation of medical images performed by investigators and those performed by blinded independent reviewers (BICR) in trials that involve imaging biomarkers.

Visit calyx.ai for more information.

About Calyx

Through innovative eClinical solutions and services, Calyx turns the uncertain into the reliable, helping bring new medical treatments to market faster. With deep expertise in clinical development and more than 25 years of supporting trial sponsors and clinical research organizations (CROs), Calyx harnesses that intelligence and activates its potential to solve complex problems, deliver fast insights, and get new drugs to market every day.

Medical Imaging | IRT | CTMS | EDC | RIM

Take your trials further, faster at calyx.ai, LinkedIn, Twitter, or Facebook.

Media Contact:

Christine Tobin | [email protected] |+1 412-628-8598


Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.